drugset / Trial / NCT00657384

Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy

NCT00657384

Phase 3 Terminated 130 enrolled University Hospital, Strasbourg, France
RandomizedParallel-groupDouble-blindPrevention

Summary

Blood loss was reported as a prognostic risk factor of morbidity and overall survival after hepatic resection. The aim of this study prospective randomized was compare the efficacy of the administration of tranexamic acid versus placebo to reduce perioperative bleeding after major hepatectomy (\> 3 hepatic segments).

Timeline

Start
2008-08-20
Primary completion
2013-08-20
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.